- Jason Edward Ochs
- September 14, 2018
While the opioid crisis has been dominating national headlines for months, denoted as one of the worst public health crises in the US’s history, children born addicted to opiates are hardly discussed. If a woman uses prescription painkillers while their…
- Jason Edward Ochs
- June 12, 2018
Pharmaceutical giant AbbVie was threatened by the FDA in December, 2017 for not properly handling complaints that its drugs had been the cause of several deaths that had not been reported to the agency. The FDA had conducted an inspection…
- Jason Edward Ochs
- June 5, 2018
San Diego-based Acadia Pharmaceuticals released their first and only drug, Nuplazid, to the market in June of 2016. Coined a “breakthrough therapy” at the time, the medication sought to relieve Parkinson’s disease patients of hallucinations and psychosis. Nuplazid was approved…
- Jason Edward Ochs
- April 15, 2018
Just within the past several months, new and staggering statistics have surfaced that really place into perspective the overall scope and devastation of the opioid epidemic that is currently ravaging just about each and every community in the country. To…
- Jason Edward Ochs
- March 27, 2018
The Food and Drug Administration (FDA) distributed a warning letter to physicians concerning the risks of using Abbott Vascular’s Absorb GT1 Bioresorbable Vascular Scaffold (BVS) on March 18th, 2017. The BVS is a stent placed into one’s coronary artery…
- Jason Edward Ochs
- January 10, 2018
Last Month, the California Supreme Court issued a controversial ruling that will allow drug manufacturers to be held liable for generic versions of the same drug manufactured by another company, even if they have sold the rights to the drug…
- Jason Edward Ochs
- August 31, 2017
The Food and Drug Administration (FDA) has declared that those without a gallbladder should not use the drug, Viberzi. The medication is used to treat Irritable Bowel Syndrome (IBS) with diarrhea. IBS is essentially the contracting of the large intestine,…
- Jason Edward Ochs
- August 27, 2017
Actemra is a drug used to treat rheumatoid arthritis, which affects 1.5 million Americans. It can be taken via injection or intravenously. With 760,000 patients worldwide, one would expect the drug to be safe; however, post-clinical studies have found that…
- Jason Edward Ochs
- August 4, 2017
Abbvie Pharmaceuticals was ordered to pay out $150 million by a federal court in Illinois for misrepresenting their drug, AndroGel. The medication is meant to treat low testosterone (Low-T) in middle age and older men. The jury found that Abbvie…
- Jason Edward Ochs
- July 31, 2017
In order to control their blood sugar levels, some diabetics use Invokana, the better-known name of the chemical canagliflozin. It is a sodium-glucose cotransporter-2. The drug functions as a cell function inhibitor. To lower the body’s blood sugar levels, Invokana…
